Primary cardiac undifferentiated sarcoma can mimic benign myxoma on echocardiography and carries a poor prognosis with rapid recurrence despite surgical resection.
Answers are grounded in this paper and cite their sources.
Warrants vigilance for sarcoma in myxoma-mimicking masses; leaves open effective strategies beyond resection in this rare entity.
The incidence of primary cardiac tumors is extremely low, ranging from 0.0017% to 0.019%.1 Primary tumors can be categorized into benign or malignant tumors, in which 75% of primary tumors are benign with myxomas comprising 50% of the cases. On the other hand, malignant tumors constitute less than 25% of primary cardiac neoplasms and are manifested predominantly as sarcoma in various forms. The clinical manifestations of cardiac tumors are protean,2 as they are dependent upon the location and the severity of obstruction or compression of valvular orifice and cardiac cavity. Therefore it is often difficult to reach the precise diagnosis prior to surgery. Although most tumors found arising from the interatrial septum and expanding into the left atrium are benign myxomas,3 an effort should be made towards a preoperative differential diagnosis. Here we reported a case of a left atrial, undifferentiated sarcoma mimicking left atrial myxoma. CASE REPORT After suffering from fever and cough for 18 days, a 14-year-old girl without documented family history of tumor was admitted to our hospital. Upon physical examination, a third degree diastolic murmur was audible in the apical region of the heart. Her pulse was steady at 140 beats/min. No abnormal finding was discovered from the routine laboratory tests. Electrocardiography (ECG) revealed a sinus tachycardia at 140 beats/min and a +185° right axis deviation. A transthoracic echocardiography was performed which identified the presence of an oval-shaped echogenic mass. The mass was mobile and lobulated with a size of approximately 57 mm × 44 mm × 34 mm. The mass was originated from the atrial fossa ovalis and extended to the left atrium with a short stem about 15 mm in width. The mass was moving during cardiac cycle, which resulted in an obstruction of the mitral valve orifice during the diastolic phase (Figure 1). A diagnosis of cardiac tumor, in specific left atrium myxoma, was made.Figure 1.: Two-dimensional transthoracic echocardiogram showing an echogenic left atrial mass. The left atrial mass obstructed orifice of the mitral valve.During the surgical operation, the patient was placed on a cardio-pulmonary bypass (CPB) apparatus with bicaval cannulas and the heart was arrested with cold blood cardioplegia. The left atrium was reached through right atrium and the interatrial septum. At the time of operation, the myxoid appearance of the tumor mass further supported the assumption of myxoma. The tumor appeared gelatinous, smooth and lobulated, resembling a benign myxoma. It was located near the top of the atrial fossa ovalis region, isabeling, approximately 5 cm × 6 cm × 6 cm in size with amicular and fundus without stem. The tumor, including a wide rim of atrial septem, was excised and subjected to pathological examination before a diagnosis of cardiac undiferentiated sarcoma was made (Figure 2). Postoperative transthoracic echocardiography (TTE) revealed the recurrence of the tumor one month after the surgery (Figure 3). The patient was put on traditional Chinese herbal medicine therapy for 1 month, and died suddenly 2 months after surgery. Her parents refused necroscopy.Figure 2.: Microscopic sections of HE staining and immunohistochemical staining. A: The tumor cells diffused in sheets with rich surrounding blood sinus (HE, original magnification ×40). B: Immunohistochemical staining for vimentin exhibiting scattered positive spots in the cytoplasm of tumor cells (original magnification ×400).Figure 3.: Recurrence of the tumor 1 month after surgery.DISCUSSION Primary cardiac malignant tumors are extremely rare. The majority are sarcomas, which account for 20%-25% of all types of tumors,4,5 including unclassified sarcoma, rhabdomyosarcoma, fibrosarcoma and leiomyosarcoma. Similar to other forms of primary cardiac tumors, there are no special clinical symptoms for patients with the undifferential sarcoma.6 The main clinical manifestations include thoracalgia, a low-grade fever, appetite loss, arrhythmia, pericardial effusion and obstructive symptoms if the tumor clogs chambers of the heart and great vessels and orifices of valves. Typically, there is no specially fixed location for the tumors. Meng and colleagues7 reported 7 cases of unclassified sarcoma. The locations, in the order of occurrence, were mitral valve (MV) + right atrium (RA) (2), RA (2), right ventricle (RV) (1), interventricular septum (IVS) (1) and pericardium (1). Bakaeen and coworkers,8 reported 4 cases of unclassified sarcoma with the locations of RA (2), left atrium (LA) (1) and RV (1). We reported the tumor arised in the atrial fossa ovalis region. The mass was mobile during the cardiac cycle, which resulted in obstruction of the mitral valve orifice during the diastolic phase. Given that all primary cardiac tumors are potentially lethal, an immediate surgery should be performed; therefore, the operation is deemed essential. In most cases of benign myxoma, surgical resection can result in a radical cure. However resection of malignant sarcoma only results in palliation of the symptoms. The prognosis of primary malignant cardiac tumors is usually poor. Bakaeen et al8 reported that the median survival time was 9.6 months and 322 months for patients with malignant and benign disease, respectively. Overall actuarial survival at 1 and 3 years was 93.5% and 92% for patients with benign disease and 47% and 24% for patients with malignant disease. Burke et al9 reported that the average survival was 11 months and the median survival was 6 months of 75 cases of primary malignant cardiac sarcoma. Therefore, it is important to distinguish the nature of the tumor prior to surgical operation. Transthoracic echocardiography has been the predominant and most reliable imaging technique to detect cardiac tumors. Myxomas are usually pedunculated with attachment to the endocardial surface near the margin of the fossa ovalis by a fibrovascular stalk.10 Most atrial myxomas have a deformable and jelly-like echocardiographic appearance whereas the others were nondeformable and firm.11 The mobility of malignant cardiac tumors is extremely rare. Usually, a benign cardiac myxoma is considered when a mobile mass is found in left atrium. In our case, the location and the mobility of the cardiac tumor were noticeable features. The tumor arised from atrial septum and could move during cardiac cycle, obstructing the mitral valve orifice during diastolic phase. These seemed to be the main reasons for the TTE and clinical diagnosis of benign myxoma. Hasegawa and Kim et al12,13 also reported 2 cases of primary cardiac sarcoma, which were pre-operatively diagnosed as benign myxomas in left atrium. TTE and transesophageal echocardiography (TEE) have been the modalities of choice for diagnosis of intracardiac masses. However, soft tissue characterization remains limited compared with that achieved by cardiac magnetic resonance imaging (MRI) and computerized tomography (CT). MRI has proved to be a very useful technique for localization and morphological characterization of a suspected mass in the heart. It is unfortunate that a CT or MRI scan was unavailable to the patient as it would probably have helped with diagnosis of her tumor and perhaps prevented its remission. For malignant cardiac tumors, the ultimate diagnosis depends on the pathological examination. Intraoperative frozen section examination and cytologic examination may be useful diagnostic tools. It is regretful that intraoperative frozen section was not performed because of the myxoid appearance of the tumor and the limited CPB time. The main aim of surgical resection is to prevent intracardiac blood flow obstruction and congestive heart failure. Surgical resection is the main treatment ranges only from gross resection to palliative resection to biopsy.8 Recurrence of the tumor is another important problem. Noriyoshi reported 2 cases of malignant cardiac tumor and both died within 6 months of the operation; although, complete excision of the tumor was macroscopically performed.14 Gowdamarajan and Michler6 reported 21 patients who underwent orthotopic heart transplantation for primary cardiac malignant neoplasms. The mean survival in the patients with malignant histology was 12 months, and there were seven patients with malignant histology who had survived for an average of 27 months without any evidence of recurrent disease.6 In this case, the tumor was removed with cautery completely, it still recurred only one month after surgery. In case of incomplete initial resection or local recurrence, we recommend that resection of all atrial myxoid tumors with wide margin (at least 1 cm), combined with intraoperative frozen section diagnosis, and heart transplantation may be a valid option. For adjuvant chemotherapy, and radiotherapy have been consistently unsuccessful,15 it poses the major challenge with clinical diagnosis before surgical treatment. Future study should focus on the method of more precise diagnosis preoperatively and advanced treatments for the primary malignant cardiac tumor in the hope for achieving cure or long term palliation.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: